Barclays PLC Sarepta Therapeutics, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 459,900 shares of SRPT stock, worth $56.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

459,900

Previous 459,900 -0.0%

Holding current value

$56.1 Million

Previous $57.4 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$124.33 - $156.75 $7.34 Million - $9.25 Million	59,002 Added 14.72%	459,900 $57.4 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $1.75 Million - $2.53 Million	15,418 Added 4.0%	400,898 $63.3 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $5.38 Million - $8.13 Million	-57,426 Reduced 12.97%	385,480 $49.9 Million
Q4 2023 Feb 15, 2024	SELL	$67.31 - $124.76 $5.01 Million - $9.28 Million	-74,380 Reduced 14.38%	442,906 $42.7 Million
Q3 2023 Nov 07, 2023	BUY	$102.5 - $123.59 $12.2 Million - $14.7 Million	118,761 Added 29.8%	517,286 $62.7 Million
Q2 2023 Aug 03, 2023	SELL	$106.4 - $157.19 $5.86 Million - $8.66 Million	-55,085 Reduced 12.14%	398,525 $45.6 Million
Q1 2023 May 04, 2023	BUY	$117.53 - $155.99 $4.54 Million - $6.02 Million	38,602 Added 9.3%	453,610 $62.5 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $13.8 Million - $18 Million	136,542 Added 49.03%	415,008 $53.8 Million
Q3 2022 Nov 03, 2022	BUY	$75.71 - $119.24 $5.19 Million - $8.17 Million	68,496 Added 32.62%	278,466 $30.8 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $9.87 Million - $13.9 Million	157,498 Added 300.16%	209,970 $15.7 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $239,401 - $342,782	-3,791 Reduced 6.74%	52,472 $4.1 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $83,694 - $107,671	1,083 Added 1.96%	56,263 $5.06 Million
Q3 2021 Nov 09, 2021	BUY	$65.97 - $92.48 $2.43 Million - $3.4 Million	36,786 Added 199.99%	55,180 $5.1 Million
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $2.46 Million - $3.08 Million	-35,492 Reduced 65.86%	18,394 $1.43 Million
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $16,111 - $37,675	223 Added 0.42%	53,886 $4.02 Million
Q4 2020 Feb 11, 2021	SELL	$125.56 - $178.74 $2.2 Million - $3.13 Million	-17,522 Reduced 24.61%	53,663 $9.15 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $13,474 - $18,268	-106 Reduced 0.15%	71,185 $10 Million
Q2 2020 Aug 12, 2020	SELL	$93.0 - $171.7 $4.79 Million - $8.84 Million	-51,498 Reduced 41.94%	71,291 $11.4 Million
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $4.6 Million - $7.34 Million	-55,791 Reduced 31.24%	122,789 $12 Million
Q4 2019 Feb 10, 2020	BUY	$76.53 - $135.58 $9.87 Million - $17.5 Million	128,999 Added 260.18%	178,580 $23 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $316,068 - $681,146	-4,341 Reduced 8.05%	49,581 $3.73 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $263,581 - $356,930	-2,349 Reduced 4.17%	53,922 $8.19 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $2.12 Million - $3.02 Million	19,887 Added 54.66%	56,271 $6.71 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $770,385 - $1.18 Million	-7,916 Reduced 17.87%	36,384 $3.97 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $13.6 Million - $19 Million	-117,809 Reduced 72.67%	44,300 $7.16 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $8.36 Million - $17.9 Million	116,470 Added 255.2%	162,109 $21.4 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $5.23 Million - $7.96 Million	-96,763 Reduced 67.95%	45,639 $3.38 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $6.51 Million - $7.76 Million	-136,740 Reduced 48.99%	142,402 $7.92 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $9.97 Million - $13.2 Million	279,142	279,142 $12.7 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account